PVLA vs DSGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PVLA Captures Institutional Edge (2โ1 Pillars ยท 2โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Momentum & Technical, Options & Structure while DSGN counters with relative strength in Growth & Margin. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PVLA Revenue | DSGN Revenue | PVLA Op. Margin | DSGN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2016 | $10M | N/A | -390.3% | N/A | PVLA |
| FY2017 | $30M | N/A | -57.7% | N/A | PVLA |
| FY2018 | $30M | N/A | -113.1% | N/A | PVLA |
| FY2019 | $40M | N/A | -62.2% | N/A | PVLA |
| FY2020 | $30M | $0M | -115.7% | -3685.8% | PVLA |
| FY2021 | $30M | N/A | -165.0% | N/A | PVLA |
| FY2022 | $30M | N/A | -167.8% | N/A | PVLA |
| FY2023 | $40M | N/A | -27.7% | N/A | PVLA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PVLA | DSGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2B | $677.5M | Larger Scale | PVLA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -63.4% | -36.9% | Higher ROE | DSGN |
| 52-Week Range Position Momentum | 68% ($72โ$180) | 30% ($7โ$17) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 75% Vol | 1.32ฮฒ ยท 61% Vol | Lower Realized Risk | DSGN |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | DSGN |